Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2009-12-31
2011-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Valuation of Variable Dose of Docosahexanoic Acid for the Improvement of the Parameters of Male Fertility
NCT02889341
The Effects of Administration of Combined Docosahexaenoic Acid and Vitamin E Supplements on Spermatogram and Seminal Plasma Oxidative Stress in Infertile Men With Asthenozoospermia
NCT01846325
Effect of Antioxidant Probiotic Administration on Seminal Quality and Reproductive Outcomes.
NCT04585984
Effect of Natural Antioxidant Supplement on Sperm DNA Fragmentation
NCT03646825
Efficacy and Safety of DA-9401 on Improvement of Sperm Motility
NCT03258437
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sunflower oil
Sunflower oil
1500 mg sunflower/day for 10 weeks
Docosahexanoic acid
Docosahexanoic acid
1500mg/day for 10 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sunflower oil
1500 mg sunflower/day for 10 weeks
Docosahexanoic acid
1500mg/day for 10 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Oncological patients.
* Patients with anticoagulants treatment.
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Barcelona
OTHER
Instituto Valenciano de Infertilidad, IVI VALENCIA
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Instituto Valenciano de infertilidad, Murcia, Spain.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martinez Soto, Juan Carlos
Role: PRINCIPAL_INVESTIGATOR
IVI Murcia
Landeras Gutierrez, Jose
Role: STUDY_DIRECTOR
IVI Murcia
Nicolas Arnau, Maria
Role: STUDY_CHAIR
IVI Murcia
Fernandez Olmedilla, Laura
Role: STUDY_CHAIR
IVI Murcia
Albero Pilar
Role: STUDY_CHAIR
IVI Murcia
Domingo JC
Role: STUDY_CHAIR
University of Barcelona
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Instituto Valenciano de infertilidad
Murcia, Murcia, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IVI MUR 005-2009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.